
Novo Nordisk Partners With OpenAI to Revolutionize Drug Discovery Pipeline
Novo Nordisk partners with OpenAI to deploy AI across drug discovery, clinical trials, manufacturing, and supply chain operations, targeting pilot programs by end of 2026.
NVOartificial intelligenceoperational efficiency